ER-Golgi network-A future target for anti-cancer therapy

Leukemia Research

Volumn 33, Issue 11, 2009, Pages 1440-1447

  Wlodkowic, Donald ^a,b   Skommer, Joanna ^b   McGuinness, Dagmara ^c   Hillier, Chris ^a   Darzynkiewicz, Zbigniew ^d  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b Cytotech Consultancy   (United Kingdom)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; Cancer; Caspases; ER; ER stress; Golgi; Therapy

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BORTEZOMIB; BREFELDIN A; BREFLATE; DEATH RECEPTOR; EEYARESTATIN I; FAS ANTIBODY; FENRETINIDE; MONOCLONAL ANTIBODY; NSC 656202; STAUROSPORINE; TETROCARCIN A; THAPSIGARGIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER THERAPY; CELL CLONE; CELL DEATH; CELL ORGANELLE; CELL STRESS; DRUG DESIGN; DRUG POTENTIATION; DRUG TARGETING; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; INTRACELLULAR SPACE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

CALCIUM; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HUMANS; NEOPLASMS;

EID: 68649102488     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.05.025     Document Type: Review

References (103)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
2. Broker L.E., Kruyt F.A., and Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 11 9 (2005) 3155-3162
3. Crighton D., and Ryan K.M. Splicing DNA-damage responses to tumour cell death. Biochim Biophys Acta 1705 1 (2004) 3-15
4. Meng X.W., Lee S.H., and Kaufmann S.H. Apoptosis in the treatment of cancer: a promise kept?. Curr Opin Cell Biol 18 6 (2006) 668-676
5. Lowe S.W., Ruley H.E., Jacks T., and Housman D.E. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 6 (1993) 957-967
6. Kaufmann S.H., and Gores G.J. Apoptosis in cancer: cause and cure. Bioessays 22 11 (2000) 1007-1017
7. Ghobrial I.M., Witzig T.E., and Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55 3 (2005) 178-194
8. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2 8 (2001) 589-598
9. Jaattela M. Programmed cell death: many ways for cells to die decently. Ann Med 34 6 (2002) 480-488
10. Lockshin R.A., and Zakeri Z. Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol 2 7 (2001) 545-550
11. Okada H., and Mak T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 4 8 (2004) 592-603
12. Edinger A.L., and Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16 6 (2004) 663-669
13. Abraham M.C., and Shaham S. Death without caspases, caspases without death. Trends Cell Biol 14 4 (2004) 184-193
14. Hail Jr. N., Carter B.Z., Konopleva M., and Andreeff M. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis 11 6 (2006) 889-904
15. Levine B., and Yuan J. Autophagy in cell death: an innocent convict?. J Clin Invest 115 10 (2005) 2679-2688
16. Kroemer G., and Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 5 11 (2005) 886-897
17. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103 8 (2005) 1551-1560
18. Kim R., Emi M., and Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57 5 (2006) 545-553
19. Ferri K.F., and Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3 11 (2001) E255-E263
20. Maag R.S., Hicks S.W., and Machamer C.E. Death from within: apoptosis and the secretory pathway. Curr Opin Cell Biol 15 4 (2003) 456-461
21. Momoi T. Caspases involved in ER stress-mediated cell death. J Chem Neuroanat 28 1-2 (2004) 101-105
22. Hicks S.W., and Machamer C.E. Golgi structure in stress sensing and apoptosis. Biochim Biophys Acta 1744 3 (2005) 406-414
23. Szegezdi E., Logue S.E., Gorman A.M., and Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7 9 (2006) 880-885
24. Orrenius S., Zhivotovsky B., and Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4 7 (2003) 552-565
25. Scorrano L., and Korsmeyer S.J. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304 3 (2003) 437-444
26. 2+: a control point for apoptosis. Science 300 5616 (2003) 135-139
27. Chipuk J.E., Maurer U., Green D.R., and Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4 5 (2003) 371-381
28. Chipuk J.E., and Green D.R. p53's believe it or not: lessons on transcription-independent death. J Clin Immunol 23 5 (2003) 355-361
29. Chipuk J.E., Bouchier-Hayes L., and Green D.R. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13 8 (2006) 1396-1402
30. Skommer J., Wlodkowic D., and Deptala A. Larger than life: mitochondria and the Bcl-2 family. Leuk Res 31 March (3) (2007) 277-286
31. Machamer C.E. Golgi disassembly in apoptosis: cause or effect?. Trends Cell Biol 13 6 (2003) 279-281
32. Rutkowski D.T., and Kaufman R.J. A trip to the ER: coping with stress. Trends Cell Biol 14 1 (2004) 20-28
33. Walter L., and Hajnoczky G. Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk. J Bioenerg Biomembr 37 3 (2005) 191-206
34. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., and Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2 6 (2000) 326-332
35. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol 1 8 (1999) 479-485
36. Patil C., and Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol 13 3 (2001) 349-355
37. McCullough K.D., Martindale J.L., Klotz L.O., Aw T.Y., and Holbrook N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21 4 (2001) 1249-1259
38. Shiraishi T., Yoshida T., Nakata S., Horinaka M., Wakada M., Mizutani Y., et al. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res 65 14 (2005) 6364-6370
39. Li J., Lee B., and Lee A.S. Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem 281 11 (2006) 7260-7270
40. Yoneda T., Imaizumi K., Oono K., Yui D., Gomi F., Katayama T., et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 276 17 (2001) 13935-13940
41. Urano F., Bertolotti A., and Ron D. IRE1 and efferent signaling from the endoplasmic reticulum. J Cell Sci 113 Pt 21 (2000) 3697-3702
42. 2+ homeostasis and apoptosis. EMBO J 23 5 (2004) 1207-1216
43. Lei K., and Davis R.J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100 5 (2003) 2432-2437
44. van de Craen M., Vandenabeele P., Declercq W., Van den Brande I., Van Loo G., Molemans F., et al. Characterization of seven murine caspase family members. FEBS Lett 403 1 (1997) 61-69
45. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 6765 (2000) 98-103
46. Nakagawa T., and Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150 4 (2000) 887-894
47. Liu H., and Baliga R. Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 16 (2005) 1985-1992
48. Morishima N., Nakanishi K., Takenouchi H., Shibata T., and Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 277 37 (2002) 34287-34294
49. Fischer H., Koenig U., Eckhart L., and Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 293 2 (2002) 722-726
50. Hitomi J., Katayama T., Eguchi Y., Kudo T., Taniguchi M., Koyama Y., et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 165 3 (2004) 347-356
51. Breckenridge D.G., Nguyen M., Kuppig S., Reth M., and Shore G.C. The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum. Proc Natl Acad Sci USA 99 7 (2002) 4331-4336
52. Thomenius M.J., and Distelhorst C.W. Bcl-2 on the endoplasmic reticulum: protecting the mitochondria from a distance. J Cell Sci 116 Pt 22 (2003) 4493-4499
53. Chen R., Valencia I., Zhong F., McColl K.S., Roderick H.L., Bootman M.D., et al. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J Cell Biol 166 2 (2004) 193-203
54. Mannella C.A., Buttle K., Rath B.K., and Marko M. Electron microscopic tomography of rat-liver mitochondria and their interaction with the endoplasmic reticulum. Biofactors 8 3-4 (1998) 225-228
55. 2+ responses. Science 280 5370 (1998) 1763-1766
56. Boehning D., Patterson R.L., Sedaghat L., Glebova N.O., Kurosaki T., and Snyder S.H. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5 12 (2003) 1051-1061
57. Guicciardi M.E., and Gores G.J. Calpains can do it alone: implications for cancer therapy. Cancer Biol Ther 2 2 (2003) 153-154
58. Sesso A., Fujiwara D.T., Jaeger M., Jaeger R., Li T.C., Monteiro M.M., et al. Structural elements common to mitosis and apoptosis. Tissue Cell 31 3 (1999) 357-371
59. Ruan Q., Wang Q., Xie S., Fang Y., Darzynkiewicz Z., Guan K., et al. Polo-like kinase 3 is Golgi localized and involved in regulation of Golgi fragmentation during the cell cycle. Exp Cell Res 294 (2004) 51-59
60. Jiang N., Wang X., Jhanwar-Uniyal M., Darzynkiewicz Z., and Dai W. Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis. J Biol Chem 281 (2006) 10577-10582
61. Wang L., Dai W., and Lu L. Stress-induced c-Jun activation mediated by Polo-like kinase 3 in corneal epithelial cells. J Biol Chem 282 (2007) 32121-32127
62. Wang Q., Xie S., Chen J., Fukasawa K., Naik U., Traganos F., et al. Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity. Mol Cell Biol 22 (2002) 3450-3459
63. Li Z., Niu J., Uwagawa T., Peng B., and Chiao P.J. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response. J Biol Chem 280 (2005) 16843-16850
64. Syed N., Smith P., Sullivan A., Spender L.C., Dyer M., Karran L., et al. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Blood 107 (2006) 250-256
65. Mancini M., Machamer C.E., Roy S., Nicholson D.W., Thornberry N.A., Casciola-Rosen L.A., et al. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 149 3 (2000) 603-612
66. Chiu R., Novikov L., Mukherjee S., and Shields D. A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis. J Cell Biol 159 4 (2002) 637-648
67. Lane J.D., Lucocq J., Pryde J., Barr F.A., Woodman P.G., Allan V.J., et al. Caspase-mediated cleavage of the stacking protein GRASP65 is required for Golgi fragmentation during apoptosis. J Cell Biol 156 3 (2002) 495-509
68. Tinel A., Tschopp J., and The PIDDosome. a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304 5672 (2004) 843-846
69. Maag R.S., Mancini M., Rosen A., and Machamer C.E. Caspase-resistant Golgin-160 disrupts apoptosis induced by secretory pathway stress and ligation of death receptors. Mol Biol Cell 16 6 (2005) 3019-3027
70. Hauser H.P., Bardroff M., Pyrowolakis G., and Jentsch S. A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J Cell Biol 141 6 (1998) 1415-1422
71. Malisan F., and Testi R. GD3 ganglioside and apoptosis. Biochim Biophys Acta 1585 2-3 (2002) 179-187
72. Rippo M.R., Malisan F., Ravagnan L., Tomassini B., Condo I., Costantini P., et al. GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J 14 13 (2000) 2047-2054
73. Tomassini B., Malisan F., Franchi L., Nicolo C., Calvo G.B., Saito T., et al. Calnexin suppresses GD3 synthase-induced apoptosis. FASEB J 18 13 (2004) 1553-1555
74. Cristea I.M., and Degli Esposti M. Membrane lipids and cell death: an overview. Chem Phys Lipids 129 2 (2004) 133-160
75. Bennett M., Macdonald K., Chan S.W., Luzio J.P., Simari R., and Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282 5387 (1998) 290-293
76. Arvan P., Zhao X., Ramos-Castaneda J., and Chang A. Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 3 11 (2002) 771-780
77. Linder S., and Shoshan M.C. Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist Updat 8 4 (2005) 199-204
78. Carew J.S., Nawrocki S.T., Krupnik Y.V., Dunner K., McConkey D.J., Keating M.J., et al. Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL. Blood 107 1 (2006) 222-231
79. Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 23 16 (2004) 2746-2756
80. Carew J.S., Nawrocki S.T., Xu R.H., Dunner K., McConkey D.J., Wierda W.G., et al. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia 18 12 (2004) 1934-1940
81. Donaldson J.G., Cassel D., Kahn R.A., and Klausner R.D. ADP-ribosylation factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-COP to Golgi membranes. Proc Natl Acad Sci USA 89 14 (1992) 6408-6412
82. Cheung H.H., Lynn Kelly N., Liston P., and Korneluk R.G. Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp Cell Res 312 12 (2006) 2347-2357
83. Shao R.G., Shimizu T., and Pommier Y. Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53. Exp Cell Res 227 2 (1996) 190-196
84. Wallen E., Sellers R.G., and Peehl D.M. Brefeldin A induces p53-independent apoptosis in primary cultures of human prostatic cancer cells. Urol 164 (2000) 836-841
85. Salles F.T., Hespanhol A.M., Jaeger R.G., and Marques M.M. Brefeldin-A induces apoptosis in human adenoid cystic carcinoma cultured cells. Oral Oncol 40 6 (2004) 585-590
86. Boya P., Cohen I., Zamzami N., Vieira H.L., and Kroemer G. Endoplasmic reticulum stress-induced cell death requires mitochondrial membrane permeabilization. Cell Death Differ 9 4 (2002) 465-467
87. Wlodkowic D., Skommer J., and Pelkonen J. Brefeldin A triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cells. Leukemia Res 31 12 (2007) 1687-1700
88. Sausville E.A., Duncan K.L., Senderowicz A., Plowman J., Randazzo P.A., Kahn R., et al. antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A. Cancer J Sci Am 2 1 (1996) 52-58
89. Phillips L.R., Supko J.G., and Malspeis L. Analysis of Brefeldin A in plasma by gas chromatography with electron capture. Anal Biochem 211 (1993) 16-22
90. Phillips L.R., Wolfe T.L., Malspeis L., and Supko J.G. Analysis of brefeldin A and the prodrug breflate in plasma by gas chromatography with mass selective detection. J Pharm Biomed Anal 16 8 (1998) 1301-1309
91. Brown J.M., and Attardi L.D. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5 3 (2005) 231-237
92. Green D.R., and Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight?. J Clin Invest 115 10 (2005) 2610-2617
93. Chapman J.R., Tazaki H., Mallouh C., and Konno S. Mechanism of Brefeldin A-induced growth inhibition and cell death in human prostatic carcinoma cells. Mol Urol 3 1 (1999) 11-16
94. Tinhoffer I., Anether G., Senfter M., Pfaller K., Bernhard D., Hara M., et al. Stressful death of T-ALL tumor cells after treatment with the anti-tumor agent Tetrocarcin-A. FASEB J 16 (2002) 1295-1297
95. Anether G., Tinhoffer I., and Greil R. Tetrocarcin-A-induced ER stress mediates apoptosis in B-CLL cells via a Bcl-2-independent pathway. Blood 101 11 (2003) 4561-4567
96. Denmeade S.R., and Isaacs J.T. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Cancer Biol & Ther 4 1 (2005) 14-22
97. Nawrocki S.T., Carew J.S., Pino M.S., Highshaw R.A., Dunner K., Huang P., et al. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res 65 24 (2005) 11658-11666
98. Hoeller D., and Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 458 7237 (2009) 438-444
99. Bennett M.K., and Kirk C.J. Development of proteasome inhibitors in oncology and autoimmune diseases. Curr Opin Drug Discov Dev 11 5 (2008) 616-625
100. Burger A.M., and Seth A.K. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer 40 15 (2004) 2217-2229
101. Hill D.S., Martin S., Armstrong J.L., Flockhart R., Tonison J.J., Simpson D.G., et al. Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma. Clin Cancer Res 15 4 (2009) 1192-1198
102. Wang Q., Mora-Jensen H., Weniger M.A., Perez-Galan P., Wolford C., Hai T., et al. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells. Proc Natl Acad Sci USA 106 7 (2009) 2200-2205
103. Boelens J., Lust S., Offner F., Bracke M.E., and Vanhoecke B.W. The endoplasmic reticulum: a target for new anticancer drugs. In Vivo 21 2 (2007) 215-226